ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Effect of Ketamine on Laboratory-induced Stress in Healthy Subjects

Phase 2

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Ketamine
Drug: Midazolam

First Posted Date: 2019-11-22

Last Posted Date: 2022-05-10

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 24

Registration Number: NCT04173962

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Real-time Biofeedback With 7-Tesla MRI for Treatment of Depression

Not Applicable

Completed

Conditions: Major Depressive Disorder

Interventions: Behavioral: Sham Biofeedback
Behavioral: Active Biofeedback

First Posted Date: 2019-10-24

Last Posted Date: 2024-08-20

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 79

Registration Number: NCT04138680

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Impact of Clinician Virtual Human Interaction Training in Emotional Self-Awareness on Patients Suicidal Ideation and Suicide Crisis Syndrome

Not Applicable

Completed

Conditions: Suicide

Interventions: Behavioral: Emotional Self Awareness (ESA) Individual Feedback

First Posted Date: 2019-10-15

Last Posted Date: 2022-11-23

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 213

Registration Number: NCT04127292

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
Florida International University, Miami, Florida, United States
🇺🇸
University of Florida, Gainesville, Florida, United States

Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)

Phase 2

Completed

Conditions: Non-small Cell Lung Cancer
Hepatocellular Carcinoma

Interventions: Drug: Nivolumab
Drug: BMS-986253
Drug: BMS-813160

First Posted Date: 2019-10-10

Last Posted Date: 2024-06-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 48

Registration Number: NCT04123379

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Assessing the Impact of Mount Sinai Parenting Center's Newborn Class

Completed

Conditions: Parenting Intervention

Interventions: Behavioral: Newborn Parenting Class

First Posted Date: 2019-10-09

Last Posted Date: 2019-10-09

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 82

Registration Number: NCT04121390

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

Asthma and Obesity: Pilot Study

Not Applicable

Completed

Conditions: Asthma
Obesity

Interventions: Behavioral: Better asthma self-management and incorporation of physical activity
Behavioral: Asthma Education

First Posted Date: 2019-10-03

Last Posted Date: 2022-11-14

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 27

Registration Number: NCT04113746

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States

Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction

Not Applicable

Recruiting

Conditions: Opiate Use Disorder

Interventions: Behavioral: Behavioral group therapy #2
Behavioral: Behavioral group therapy #1

First Posted Date: 2019-10-02

Last Posted Date: 2024-08-13

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 220

Registration Number: NCT04112186

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment

Not Applicable

Recruiting

Conditions: Alzheimer's Disease
Mild Cognitive Impairment

Interventions: Device: Lighting Intervention

First Posted Date: 2019-08-29

Last Posted Date: 2024-08-01

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 120

Registration Number: NCT04073628

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Efficacy Of Quadratus Lumborum II Block For Laparoscopic Sleeve Gastrectomy

Phase 4

Completed

Conditions: High BMI
Morbid Obesity

Interventions: Drug: Bupivacaine

First Posted Date: 2019-08-28

Last Posted Date: 2023-01-05

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 41

Registration Number: NCT04073056

Locations: 🇺🇸
Mount Sinai St. Lukes Hospital, New York, New York, United States

Assessing the Effectiveness of an N-of-1 Platform Using Study of Cognitive Enhancers

Phase 4

Terminated

Conditions: Cognitive Performance

Interventions: Dietary Supplement: Caffeine supplement
Drug: L-theanine
Device: N1 app

First Posted Date: 2019-08-14

Last Posted Date: 2021-03-12

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 57

Registration Number: NCT04056650

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy